Section of Pediatric Allergy and Immunology at Baylor College of Medicine
Located at Texas Children's Hospital, Baylor's primary teaching hospital for pediatrics, the Section of Allergy and Immunology and Clinic provide diagnosis and treatment for adult and pediatric patients with allergy, asthma, and primary or secondary immune dysfunction. The expanding spectrum of complex allergic and immunologic diseases now being seen by specialists in allergy and immunology includes hypersensitivity diseases, severe asthma, antibody deficiencies, and cellular immune defects requiring immune reconstitution. With over 20 years of continuous external-sponsored funding of basic and clinical research, we offer our patients the most up-to-date treatment of allergic and immunological disorders.
Our faculty includes experts in allergic rhinitis, asthma, genetic immunodeficiencies, and acquired immunodeficiencies, who specialize in immunoreconstitution of these illnesses with allergen-specific immunotherapy, intravenous immunoglobulin replacement therapy, bone marrow stem cell transplantation, highly active antiretroviral therapy, and immunomodulatory therapy with fusion proteins.Our professional staff includes faculty, clinical fellows, nurse practitioners, a certified nurse midwife, clinical and research nurses, social workers, research and clinical laboratory technicians, and administrative support personnel.
Since 1982, the Section of Allergy and Immunology has cared for HIV-infected children, and in 1988 we established what has become one of the leading NIH-funded Pediatric HIV/AIDS Research Centers in the country, the Texas Children's HIV Center. As part of the nationwide Pediatrics AIDS Clinical Trials Group and Pediatric HIV/AIDS Cohort Study, sponsored by the National Institutes of Health, the HIV Center provides a variety of research and treatment options for infants, children, adolescents, and pregnant women with HIV infection. All of this activity has had a beneficial impact upon the unfortunate infants and children with this affliction, in that it provides an avenue for the most up-to-date antiretroviral treatments, including protease inhibitors and immunotherapy.
